Scientific publications
The selection prioritises recent clinical, comparative and randomised research and also includes clearly identified preclinical work. The summaries do not constitute treatment recommendations.
01 — The studies
Six publications, listed with their year, study design and population. The complete articles are available to healthcare professionals and professional buyers on request.
2025 · Prospective · randomised · n = 91
A sham-controlled trial compared three groups of patients with lateral epicondylitis. After 12 weeks, the combination of PRP, shock-wave therapy and exercise achieved better clinical outcomes for pain, function and grip strength; ultrasonographic parameters did not differ between the groups.
2026 · Preclinical · animal model · n = 28
A skeletal-muscle injury model in 28 rabbits directly compared Exomine®, T‑LAB PRP®, Arthrex ACP® and a control group. T‑LAB and Arthrex achieved comparable, approximately 2.5- to 3-fold platelet enrichment with no statistically significant difference. Exomine showed a more favourable histological profile of inflammation and scarring, but the results are preclinical and require clinical confirmation.
2024 · Randomised controlled · n = 84
Three groups compared PRP, supervised exercise and their combination in mild to moderate knee osteoarthritis. The registered randomised study monitored pain and function.
2023 · Diagnostic · level IV · n = 62
In 62 patients with knee osteoarthritis, preparation with the T‑LAB system achieved a dose of 3.25 billion platelets, 77% recovery and 98.4% PRP purity (DEPA classification B-B-A). The study also analysed the influence of baseline platelet count and individual factors.
2025 · Retrospective cohort · 150 patients · 205 knees
The cohort study compared pain and function after four approaches in grade 2–3 osteoarthritis. The authors emphasise the retrospective design and individual clinical judgement.
2019 · Comparative clinical · n = 40
In 40 patients with chronic shoulder pain, ultrasound-guided PRP and cortisone injections were compared. Both groups improved in pain and function at one and two months; pain reduction at two months was greater in the PRP group.
